APPLICATION OF SELEGILIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREPARING A PHARMACEUTICAL PREPARATION INTENDED FOR TREATING EPILEPTIC DISEASES

摘要

The use of selegiline (L-N (1-phenylisopropyl) -N-meth-N-propylamine) or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of epileptic diseases, in particular for controlling convulsions and for slowing the development of diseases.